- Home
- ALLT vs KOD Comparison
ALLT vs KOD Comparison
Compare ALLT & KOD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALLT
- KOD
- Stock Information
- Founded
- ALLT 1996
- KOD 2009
- Country
- ALLT Israel
- KOD United States
- Employees
- ALLT N/A
- KOD N/A
- Industry
- ALLT Telecommunications Equipment
- KOD Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ALLT Telecommunications
- KOD Health Care
- Exchange
- ALLT Nasdaq
- KOD Nasdaq
- Market Cap
- ALLT 229.8M
- KOD 259.6M
- IPO Year
- ALLT 2006
- KOD 2018
- Fundamental
- Price
- ALLT $8.30
- KOD $3.83
- Analyst Decision
- ALLT Buy
- KOD Hold
- Analyst Count
- ALLT 1
- KOD 3
- Target Price
- ALLT $13.00
- KOD $9.00
- AVG Volume (30 Days)
- ALLT 321.2K
- KOD 468.7K
- Earning Date
- ALLT 05-12-2025
- KOD 05-23-2025
- Dividend Yield
- ALLT N/A
- KOD N/A
- EPS Growth
- ALLT N/A
- KOD N/A
- EPS
- ALLT N/A
- KOD N/A
- Revenue
- ALLT $93,455,000.00
- KOD N/A
- Revenue This Year
- ALLT $6.43
- KOD N/A
- Revenue Next Year
- ALLT $5.83
- KOD N/A
- P/E Ratio
- ALLT N/A
- KOD N/A
- Revenue Growth
- ALLT N/A
- KOD N/A
- 52 Week Low
- ALLT $2.02
- KOD $1.92
- 52 Week High
- ALLT $9.44
- KOD $11.60
- Technical
- Relative Strength Index (RSI)
- ALLT 69.53
- KOD 54.50
- Support Level
- ALLT $5.61
- KOD $3.75
- Resistance Level
- ALLT $8.70
- KOD $4.30
- Average True Range (ATR)
- ALLT 0.48
- KOD 0.43
- MACD
- ALLT 0.27
- KOD -0.03
- Stochastic Oscillator
- ALLT 78.76
- KOD 25.68
About ALLT Allot Ltd.
Allot Ltd is a provider of network intelligence and security solutions for service providers and enterprises. The company's solutions are deployed globally for network and application analytics, traffic control and shaping, and network-based security services. The firm's multi-service platforms are deployed by mobile, fixed, and cloud service providers and enterprises. It has a customer base in Europe, Asia and Oceania, the Americas, the Middle East, and Africa.
About KOD Kodiak Sciences Inc
Kodiak Sciences Inc is a biopharmaceutical company specializing in novel therapeutics to treat high-prevalence retinal diseases. The product candidate of the company is BLA, which is a novel antibody biopolymer conjugate, in treatment-naive subjects with neovascular wet AMD. The pipeline products of the company include Tarcocimab tedromer, KSI-501, and KSI-101.